---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-26-000003"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2026-01-02T23:59:59+00:00"
generated_at: "2026-05-16T11:48:51.994448+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Salarius shareholders re-elect directors, approve executive compensation, ratify EY as auditor

## Summary
- Votes for Hanish: 143,525; against: 11,932; abstain: 5,761; broker non-votes: 256,225.
- Votes for McVicar: 143,599; against: 10,058; abstain: 7,561; broker non-votes: 256,225.
- Advisory vote on executive compensation approved: 132,240 for, 22,606 against, 6,372 abstentions; broker non-votes: 256,225.
- Ratification of Ernst & Young LLP as auditor: 401,439 for, 12,132 against, 3,872 abstentions.
- Quorum achieved: 417,443 shares present (39.7% of 1,051,782 outstanding).

## SEC filing metadata
- accession: 0001615219-26-000003
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2026-01-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521926000003/0001615219-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521926000003/flks-20251231.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-26-000003
- JSON: https://secwatch.observer/filing/0001615219-26-000003.json
- Plain text: https://secwatch.observer/filing/0001615219-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.